Replies to post #74290 on Biotech Values

[corpstrat]

DNA - You have not yet taken me up on the survey suggestion. How many of the top 5 science execs will still be at Genentech 9 months after merger close? I'd say 1, at best.

[DewDiligence]

DNA – Addendum to the market-cap table in #msg-36224216: more than two-thirds of the pro forma market cap of the “new” Roche is attributable to DNA.